David Farley Johnson

Title: David Farley Johnson: Innovator in Parenteral Administration

Introduction

David Farley Johnson is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of parenteral administration. With a total of 2 patents, Johnson's work focuses on innovative solutions for medical applications.

Latest Patents

Johnson's latest patents include "Nonaqueous compositions for parenteral administration" and "Implant compositions containing a biologically active protein, peptide." The first patent provides nonaqueous compositions that comprise a saccharide fatty acid ester and an active compound. These compositions are designed for parenteral administration to both animals and humans, specifically targeting the prevention, control, or treatment of helminth, acarid, or arthropod infections. The second patent relates to implants that deliver a continuous amount of biologically active proteins, peptides, or polypeptides over an extended period. This invention aims to maintain elevated blood levels of these biologically active substances in animals.

Career Highlights

David Farley Johnson is associated with American Cyanamid Company, where he has contributed to various innovative projects. His work has been instrumental in advancing the field of pharmaceutical formulations, particularly in the development of effective parenteral delivery systems.

Collaborations

Johnson has collaborated with notable coworkers such as James M Quinlan and William David Steber. Their combined expertise has fostered a productive environment for innovation and development in their respective fields.

Conclusion

David Farley Johnson's contributions to the field of parenteral administration highlight his role as an influential inventor. His innovative patents and collaborations continue to impact the pharmaceutical industry positively.